.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Covington
Julphar
Healthtrust
Queensland Health
QuintilesIMS
Deloitte
Boehringer Ingelheim
Cerilliant

Generated: September 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Orally disintegrating tablets with speckled appearance
Abstract: Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.
Inventor(s): Stroppolo; Federico (Mezzovico, CH), Ardalan; Shahbaz (Mezzovico, CH)
Assignee: Alpex Pharma SA (Mezzovico, CH)
Application Number:12/811,737
Patent Claims: 1. An orally disintegrating tablets with speckled appearance comprising (a) speckles comprising colored granules of a water-soluble sugar, and (b) a pharmaceutically acceptable carrier.

2. The orally disintegrating tablets according to claim 1 wherein the water-soluble sugar is selected from the group consisting of sucrose and polyalcohols.

3. The orally disintegrating tablets according to claim 2 wherein the water-soluble sugar is selected from the group consisting of sucrose, sorbitol, mannitol, xylitol, and fructose.

4. The orally disintegrating tablets according to claim 3 wherein the water-soluble sugar is mannitol.

5. The orally disintegrating tablets according to claim 1 wherein the colored granules have a particle size from about 10 .mu.m to about 1200 .mu.m.

6. The orally disintegrating tablets according to claim 5 wherein the colored granules have a particle size from about 200 .mu.m to about 800 .mu.m.

7. The orally disintegrating tablets according to claim 6 wherein the colored granules have a particle size from about 300 .mu.m to about 500 .mu.m.

8. The orally disintegrating tablets according to claim 1 wherein the colored granules are present in an amount from about 0.1% w/w to about 50% w/w per tablet.

9. The orally disintegrating tablets according to claim 1 wherein the colored granules are present in an amount from about 1% w/w to about 30% w/w.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
UBS
Dow
Moodys
Farmers Insurance
Queensland Health
Fish and Richardson
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot